Corrina M.A. de Ridder

Targeting the Androgen Receptor Confers In Vivo Cross-resistance Between Enzalutamide and Docetaxel, But Not Cabazitaxel, in Castration-resistant Prostate Cancer

Robert J. van Soest, Ellen S. de Morrée, Charlotte F. Kweldam et al. · European Urology · 2014 · 130 citations

Medicine, Oncology, Pharmacology +16

High Efficacy of Combination Therapy Using PI3K/AKT Inhibitors with Androgen Deprivation in Prostate Cancer Preclinical Models

Rute B. Marques, Ashraf Aghai, Corrina M.A. de Ridder et al. · European Urology · 2014 · 99 citations

Medicine, Oncology, Pharmacology +17

Movember GAP1 PDX project: An international collection of serially transplantable prostate cancer patient‐derived xenograft (PDX) models

Nora M. Navone, Wytske M. van Weerden, Robert L. Vessella et al. · The Prostate · 2018 · 88 citations · Full text

Medicine, Oncology, Translational Sciences +8

Activation of c-MET Induces a Stem-Like Phenotype in Human Prostate Cancer

Geert J.L.H. van Leenders, Rajesh Sookhlall, Wilma J. Teubel et al. · PLoS ONE · 2011 · 76 citations · Full text

Medicine, Cell Biology, Oncology +17

Androgen-dependent expression of the gastrin-releasing peptide receptor in human prostate tumor xenografts.

M. Visser, Wytske M. van Weerden, Corrina M.A. de Ridder et al. · PubMed · 2007 · 56 citations

Medicine, Oncology, Pharmacology +17